These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 5013315

  • 1. [Current analysis of galenic preparations with regard to the 4th edition of the Polish Pharmacopoiea (FP IV)].
    Nerlo H.
    Cesk Farm; 1972 Feb; 21(1):25-8. PubMed ID: 5013315
    [No Abstract] [Full Text] [Related]

  • 2. [The history of dosage form from the German Pharmacopoeia I to II of East Germany].
    Heise HG, Heise J.
    Pharmazie; 1984 Jul; 39(7):445-61. PubMed ID: 6494224
    [No Abstract] [Full Text] [Related]

  • 3. [Dispersion analysis of drug forms].
    Gorbunova TV, Nazarov BV.
    Farm Zh; 1975 Jul; (5):19-26. PubMed ID: 773672
    [No Abstract] [Full Text] [Related]

  • 4. [Various galenic forms of the V Belgian Pharmacopoeia. V. Gelatin-coated pills, tablets, unguents, syrups, suppositories].
    Jaminet F.
    Farmaco Prat; 1969 Oct; 24(10):593-641. PubMed ID: 5361891
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Advances in pharmaceutical technology in 1966-1967. II. Drugs and pharmaceutical preparations].
    Chalabala M, Malý J, Burelová A, Starha L, Heliová M, Rak J, Rehula A.
    Cesk Farm; 1968 Nov; 17(9):450-61. PubMed ID: 4888356
    [No Abstract] [Full Text] [Related]

  • 7. [Measure of the dimension of drug particles. Necessity of norms].
    Renoz L.
    J Pharm Belg; 1971 Nov; 26(2):166-82. PubMed ID: 5560485
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Homogeneity of pharmaceutical dispersed systems.
    Hersey JA, Cook PC.
    J Pharm Pharmacol; 1974 Feb; 26(2):126-33. PubMed ID: 4150829
    [No Abstract] [Full Text] [Related]

  • 13. Content uniformity acceptance limit for a validation batch--suppositories, transdermal systems, and inhalations.
    Senderak ET.
    Drug Dev Ind Pharm; 2009 Jun; 35(6):735-7. PubMed ID: 19514989
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Sedimentation and sedimentation retarders, especially celluloses, with a pharmacopoeia proposal "cellulose powder"].
    Graf E, Graser M, Walker R.
    Arch Pharm Ber Dtsch Pharm Ges; 1971 Mar; 304(3):61-84. PubMed ID: 4946886
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ophthalmic dosage forms in medieval Persia.
    Zarshenas MM, Hosseinkhani A, Zargaran A, Kordafshari G, Mohagheghzadeh A.
    Pharm Hist (Lond); 2013 Mar; 43(1):6-8. PubMed ID: 24620536
    [No Abstract] [Full Text] [Related]

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1980 Mar; 645():1-54. PubMed ID: 6774485
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.